Premium
Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial
Author(s) -
PedersenBjergaard J.,
Nissen N.I.,
Brincker H.,
Ellegaard J.,
Drivsholm A.,
Freund L.,
Jensen K.B.,
Jensen M. Krogh
Publication year - 1987
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.1987.tb00023.x
Subject(s) - daunorubicin , aclarubicin , cytarabine , medicine , refractory (planetary science) , leukemia , oncology , gastroenterology , astrobiology , physics
SUMMARY The results of this trial have been published elsewhere (1).